Citation 37742

VISCONTI,A: MINERVINI,F: LUCIVERO,G: GAMBATESA,V:. (1991). CYTOTOXIC AND IMMUNOTOXIC EFFECTS OF FUSARIUM MYCOTOXINS USING A RAPID COLORIMETRIC BIOASSY.. 113(3)

Citation Details

TitleCYTOTOXIC AND IMMUNOTOXIC EFFECTS OF FUSARIUM MYCOTOXINS USING A RAPID COLORIMETRIC BIOASSY.
AuthorsVISCONTI,A: MINERVINI,F: LUCIVERO,G: GAMBATESA,V:
Year1991
Volume113
Issue3

Summary

Year: 1991

Journal: Unknown

Organisms and Their Experiments (23)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
T-2 TOXIN
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
T-2 TOXIN
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
T-2 TOXIN
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
HT-2 TOXIN
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
HT-2 TOXIN
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
HT-2 TOXIN
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
T-2 TOXIN,ACETYL:
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
T-2 TOXIN,ACETYL:
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
T-2 TOXIN,ACETYL:
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
T-2 TRIOL
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
T-2 TRIOL
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
T-2 TRIOL
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
T-2 TETRAOL
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
T-2 TETRAOL
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
T-2 TETRAOL
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SOLANIOL,NEO: 8-ACETOXY:
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SOLANIOL,NEO: 8-ACETOXY:
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
SOLANIOL,NEO: 8-ACETOXY:
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ACUMINATIN
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ACUMINATIN
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ACUMINATIN
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
T-2 TETRAOL,TETRACETOXY:
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
T-2 TETRAOL,TETRACETOXY:
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
T-2 TETRAOL,TETRACETOXY:
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SOLANIOL,NEO:
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SOLANIOL,NEO:
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
SOLANIOL,NEO:
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
T-2 TETRAOL,4-8-DIACETOXY:
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
T-2 TETRAOL,4-8-DIACETOXY:
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
T-2 TETRAOL,4-8-DIACETOXY:
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SCIRPENOL,DIACETOXY:
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
SCIRPENOL,DIACETOXY:
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
SCIRPENOL,DIACETOXY:
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FUSARENON X
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FUSARENON X
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
FUSARENON X
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NIVALENOL
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NIVALENOL
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
NIVALENOL
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
VOMITOXIN
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
VOMITOXIN
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
VOMITOXIN
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NIVALENOL,DEOXY: 15-ACETYL:
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NIVALENOL,DEOXY: 15-ACETYL:
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
NIVALENOL,DEOXY: 15-ACETYL:
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NIVALENOL,DEOXY: 3-ACETYL:
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
NIVALENOL,DEOXY: 3-ACETYL:
ACTIVE
3
LYMPHOCYTE BLASTOGENESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
NIVALENOL,DEOXY: 3-ACETYL:
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FUSARIN C
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FUSARIN C
ACTIVE
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FUSARIN C
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MONILIFORMIN
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MONILIFORMIN
ACTIVE
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
MONILIFORMIN
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ZEARALENONE
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ZEARALENONE
ACTIVE
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ZEARALENONE
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ZEARALENOL,ALPHA:
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ZEARALENOL,ALPHA:
ACTIVE
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ZEARALENOL,ALPHA:
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ZEARALEANOL,BETA:
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ZEARALEANOL,BETA:
ACTIVE
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ZEARALEANOL,BETA:
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FUSARIUM ANTIBIOTIC Y
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FUSARIUM ANTIBIOTIC Y
ACTIVE
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
FUSARIUM ANTIBIOTIC Y
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BIKAVERIN
ACTIVE
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BIKAVERIN
ACTIVE
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BIKAVERIN
ACTIVE
Show SPARQL Queries (1)